DOI:
10.1055/s-00000180
Journal of Neurological Surgery Part A: Central European Neurosurgery
LinksClose Window
References
Long GV, Trefzer U, Davies MA. , et al.
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial.
Lancet Oncol 2012;
13 (11) 1087-1095
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.